Citadel Advisors’s LifeVantage LFVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-24,300
Closed -$354K 13942
2025
Q1
$354K Sell
24,300
-10,600
-30% -$200K ﹤0.01% 9228
2024
Q4
$612K Buy
34,900
+8,700
+33% +$122K ﹤0.01% 8109
2024
Q3
$316K Buy
+26,200
New +$217K ﹤0.01% 9221
2024
Q1
Sell
-9,400
Closed -$56.4K 15087
2023
Q4
$56.4K Sell
9,400
-3,100
-25% -$20.5K ﹤0.01% 11651
2023
Q3
$80.6K Buy
12,500
+9,400
+303% +$52.6K ﹤0.01% 11169
2023
Q2
$13.5K Buy
3,100
+900
+41% +$3.72K ﹤0.01% 13037
2023
Q1
$7.9K Buy
2,200
+1,000
+83% +$3.75K ﹤0.01% 13692
2022
Q4
$4.46K Buy
+1,200
New +$4.57K ﹤0.01% 14095
2019
Q1
Sell
-21,700
Closed -$286K 9616
2018
Q4
$286K Buy
21,700
+4,300
+25% +$51.5K ﹤0.01% 7351
2018
Q3
$191K Buy
+17,400
New +$185K ﹤0.01% 8242

Other funds holding LFVN

Citadel Advisors's LFVN Position: Q1 2026 in Review

Citadel Advisors increased its LifeVantage (LFVN) stake by 0.2% in Q1 2026, buying an estimated $791 and bringing the position to 76,510 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #10264.

Citadel Advisors first reported a position in LFVN in Q3 2013 and has held it in 23 quarters since. The position peaked at $897K in Q1 2014. 104 funds tracked by Wall St. Rank hold LFVN as of Q1 2026.

  • Citadel Advisors held 76,510 shares of LifeVantage worth $331K as of Q1 2026.
  • Citadel Advisors bought 151 LifeVantage shares in Q1 2026, an estimated $791.
  • LifeVantage made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #10264 holding.
  • Citadel Advisors first reported a position in LifeVantage in Q3 2013 and has held it in 23 quarters since.
  • Citadel Advisors's LifeVantage position peaked at $897K in Q1 2014.
  • 104 funds tracked by Wall St. Rank held LifeVantage as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.